June 14, 2022 from 5:30-9:00pm
South Coast Winery
34843 Rancho California Rd, Temecula, CA 92591
Enjoy an evening of inspired conversations featuring Keynote Tara Lynn Gray, Director, Office of the Small Business Advocate and innovative presentations the Murrieta Innovation Center entrepreneurs and innovators.
Add a description about this category
Murrieta Genomics is dedicated to finding those answers and advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise.
SimplSeq has developed a proprietary process to prepare biological samples for next generation genomic sequencing processing that will save thousands of labs a great deal of time and expense. While the time and cost of the sequencing of DNA and RNA has dropped substantially, the process of extracting DNA or RNA from a biological sample, purifying it, and making enough copies to get a good read has basically remained the same.
GattaCo Inc. is a young Southern California startup company that develops solutions for the life science and medical industry.
GattaCo’s mission is to enable next generation diagnostics and simplified sample collection and processing. We do this by leveraging our patented Capillary Pressure Re-Set (or Cap-Reset™) Technology to create novel products and solutions for our partners.
Swellter is a patient immersion platform that is enriching the oncology patient-provider experience through consent, education, and data sharing in real-time. Swellter opens a window through which laboratory and pharmaceutical companies can share relevant and potentially transformative diagnostic and therapeutic options with oncologists and cancer patients. We are steadfast in building a transformative platform that will change the patient experience and engage all oncology stakeholders.
Neyroblast GX's focus is to develop next-generation theranostic products for neurodegenerative and infectious diseases like Alzheimer’s disease and COVID-19. We also have a platform to provide custom-made human organoids and genetically engineered cells for screening drug, toxicity, and disease pathology. Our team of scientists comes from a range of backgrounds across academia, biotech, and pharma with extensive experience in nutraceutical biomedicine, genetics, neurobiology, drug develop
Parthen, Inc. was formed in 2021 to utilize advances in genomic sequencing and telehealth technologies in order to provide a patient-centered approach to precision cancer care.
Virtually everyone’s life has been affected by cancer in one way or another, but we are never prepared for that moment when we ourselves are diagnosed with the disease. It is a gut-wrenching moment that fills one with dread and fear.
Parthen wants to provide a “comfort zone” for patients, where they can get answers to th
TX Genetic Research offers personalized health and wellness services and products based on an individual's whole exome sequencing (WES) genetic profile and their health symptoms.
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company pioneering dual action drugs to generate immunogenic tumors. TRIO's innovative antibody drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. TRIO is developing a proprietary platform of dual action tumor immunity-enhancing drugs aimed at treating cancers of high unmet medical needs by targeting specific antigens on the cancer cells an
Gnomegen focuses on clinical ready reagent, consumable and instrument development. Gnomegen’s current pipeline of products are based on digital PCR and next generation sequencing. Alongside COVID-19 EUA kit, Gnomegen will continue develop and register additional FDA products on viral and liquid biopsy detection.
Add a footnote if this applies to your business